Skip to content
Cornea Specialist · Keratoplasty · Eye treatments

Corneal Transplant & Keratoplasty in Turkey — DALK, PK and DMEK at Eyeglow Istanbul

Cornea-specialist-led transplant surgery using EBAA-graded donor tissue — Deep Anterior Lamellar Keratoplasty (DALK), Penetrating Keratoplasty (PK), and Descemet Membrane Endothelial Keratoplasty (DMEK). Every case reviewed by our cornea specialist team, with complication insurance, structured 12-month follow-up and a single named coordinator throughout.

Slit-lamp views of a clouded cornea and a sutured donor graft after keratoplasty — Eyeglow Health, Istanbul
Procedure time~1 hour
AnaesthesiaTopical + sedation or general
Hospital stayDay case (no overnight)
Time in Istanbul7–10 nights
Visual recovery3–12 months (graft type)
Follow-up1 year structured
What it is

What is corneal transplant surgery?

Corneal transplantation — keratoplasty — replaces damaged corneal tissue with EBAA-graded donor tissue to restore corneal clarity and visual function. Three techniques are used at Eyeglow Health: DALK (anterior stroma only, endothelium preserved), Penetrating Keratoplasty (full-thickness replacement), and DMEK (posterior Descemet layer and endothelium only) — matched to each patient's corneal pathology.

Corneal transplantation is indicated when disease, scarring or endothelial failure has reduced the cornea's optical clarity or structural integrity beyond what contact lenses, cross-linking, or ring segments can manage. At Eyeglow Health in Istanbul, every keratoplasty case is planned by our cornea specialist team using Pentacam Scheimpflug topography, anterior-segment OCT and specular endothelial cell count — consistent with American Academy of Ophthalmology (AAO) Preferred Practice Pattern on Corneal Edema and Opacification (2018), the Cornea Society Preferred Practice Patterns, NICE IPG585 (DMEK, 2017) and Eye Bank Association of America (EBAA) tissue standards.

Corneal transplant is a major intraocular surgical procedure with a defined recovery period (3 to 18 months depending on technique) and a lifelong steroid maintenance requirement. It is not appropriate for every patient with reduced corneal clarity. Active infection, uncontrolled glaucoma, severe posterior segment disease or poor ocular surface health must be addressed before transplant — and realistic visual prognosis is discussed frankly with every patient before the donor tissue request is filed.

How it works

From first consultation to graft maturation

  1. 01

    Online cornea review and donor request

    You share topography (Pentacam preferred), pachymetry maps, refraction history, slit-lamp photos or video, and the diagnosis confirmed by your local ophthalmologist. Our cornea specialist team reviews your case to confirm the diagnosis, whether the fellow eye is at risk, and which keratoplasty technique matches your corneal pathology — before a donor tissue request is filed with our partner eye bank.

  2. 02

    Donor tissue and EBAA-grading confirmation

    Donor corneas procured for our procedures are graded to Eye Bank Association of America (EBAA) criteria — specular endothelial cell count ≥2,000 cells/mm², age-appropriate tissue, no active infection and full donor serology. For DMEK, the Descemet membrane is pre-stripped by the eye bank to confirm peel integrity before the tissue is dispatched. Tissue availability typically requires 1 to 2 weeks notice; urgent clinical cases are prioritised.

  3. 03

    Pre-operative imaging in Istanbul

    Day 1 in Istanbul: Pentacam Scheimpflug topography, anterior-segment OCT (AS-OCT), specular endothelial cell count, slit-lamp biomicroscopy and biometry if IOL power calculation is needed (combined triple procedure). These confirm the correct technique, K readings, anterior chamber depth and the status of the fellow eye.

  4. 04

    The procedure (about 1 hour)

    DALK: the anterior 95% of the corneal stroma is removed using pneumatic deep dissection (big-bubble technique) or manual lamellar dissection, preserving the patient's Descemet membrane and endothelium. The donor stroma is sutured into place. DMEK: a thin scroll of donor Descemet membrane and endothelium only is injected into the anterior chamber through a small incision and unfolded with an air bubble — no sutures required in the cornea itself. PK: full-thickness donor button sutured with 16 or combined sutures; used when both stroma and endothelium are diseased or scarred to the visual axis.

  5. 05

    Post-operative reviews and steroid management

    DMEK patients return on day 1 for air-bubble position check; a second small air injection is available in clinic if needed. DALK and PK patients are reviewed on day 1 and day 5. Topical steroid drops (prednisolone acetate 1%) are prescribed long-term — typically one year or lifelong — to reduce rejection risk. A structured tapering protocol is provided in writing with your discharge summary.

  6. 06

    One-year structured aftercare

    Scheduled video reviews at one, three, six and twelve months. Slit-lamp photos, endothelial cell counts and Pentacam scans are repeated at each milestone to document graft clarity, cell density and rejection-free status. Suture removal timing (PK/DALK) is guided by topographic astigmatism, not fixed schedule. Your named coordinator manages the entire pathway.

Treatment options

DALK vs Penetrating Keratoplasty vs DMEK — which keratoplasty is right for you?

The keratoplasty technique is determined by which corneal layer is diseased. Here is how the three approaches differ in practice:

AspectDALKPenetrating Keratoplasty (PK)DMEK
What is replacedAnterior stroma only — Descemet + endothelium preservedFull-thickness cornea — all layersDescemet membrane + endothelium only
Ideal patientAdvanced keratoconus, stromal scarring, anterior dystrophies with healthy endotheliumFull-thickness stromal scarring, severe infections reaching endothelium, previously failed DALKFuchs endothelial dystrophy, bullous keratopathy, posterior corneal failure with clear stroma
Rejection rateEndothelial rejection near zero (own endothelium retained); stromal rejection <5%Endothelial rejection 10–20% at 5 years; immunosuppressive drops required lifelongRejection 1–4% at 5 years — substantially lower than PK; DMEK is the endothelial standard of care
Visual recoveryBest corrected vision returns at 6–12 months as astigmatism settles; spectacle correction still commonBest corrected vision at 12–18 months; irregular astigmatism requires rigid contact lens in many casesFunctional vision at 4–8 weeks; near-normal endothelial function within 3 months
Sutures16 interrupted or combined sutures — selective removal guided by topography16 interrupted or combined sutures — selective removal guided by topographyNo corneal sutures — incision closed with 1–2 scleral sutures only
Donor tissue grading (EBAA)Endothelial count ≥2,000 cells/mm² required; donor age and tissue thickness factorEndothelial count ≥2,000 cells/mm²; whole-button prepared by eye bankEndothelial count ≥2,500 cells/mm² preferred; Descemet pre-stripped and integrity confirmed before dispatch
Pricing

Corneal transplant pricing

All-inclusive Eyeglow package pricing. Your final, personalised quote is confirmed after imaging review — with no obligation.

Procedure Eyeglow price (all-inclusive)
Corneal Transplant (DALK / PK / DMEK) — per eye, donor tissue included, all-inclusive€7,000 – €10,000
Package transparency

What's included in your corneal transplant package

Included in package

  • Pre-op imaging (Pentacam topography, anterior OCT, specular endothelial count, slit-lamp, biometry)
  • Cornea specialist team consultation + technique review
  • Donor corneal tissue — EBAA-graded, full serological clearance
  • DALK / PK / DMEK procedure including anaesthesia and theatre
  • Day-case procedure — no overnight hospital stay
  • 5-star hotel — 7 nights
  • VIP airport transfers (return)
  • Post-op drops kit (steroids, antibiotics, lubricants)
  • Day-1, day-5, 1m, 3m, 6m, 12m review (slit-lamp + endothelial count + Pentacam)
  • Multilingual cornea coordinator — 24/7
  • Complication insurance policy (Türkiye Ministry of Health certified, covers surgical complications including infection, retreatment, and emergency intervention up to package value)

Paid separately

Items below are not part of the medical package — your coordinator helps arrange them at no markup.

  • Flights to/from Istanbul
  • Personal expenses
  • Specialty rigid / scleral contact lens fitting after surgery (optional, quoted separately)
  • Suture removal visits beyond the 12-month structured pathway (rare, case-by-case)
  • Unrelated medical treatments
  • Travel insurance (recommended — covers flight cancellation, baggage, non-surgical medical emergencies abroad; we coordinate referral if needed)
Our team

The surgeons who will care for you

Your procedure is carried out by our cornea specialist team at our partner accredited hospital in Istanbul. Their training and sub-specialty focus are shown below.

Medically reviewed by Assoc. Prof. Dr. Muhammet Derda Özer, FICO

From our practice

Keratoplasty outcomes from our own cases

The images below are from corneal transplant (keratoplasty) cases managed by our surgical team in Istanbul — documented before surgery and after graft healing. They are shared to illustrate the conditions our team treats, not as a guarantee of any individual outcome.

Corneal transplant (keratoplasty) managed by the Eyeglow Health surgical team in Istanbul — before and after graft healing
Penetrating keratoplasty with sutured donor graft managed by the Eyeglow Health surgical team in Istanbul — before and after

Clinical images are published with documented patient consent and are from procedures performed by our own surgical team. Individual results vary with corneal condition, graft type and healing; these images do not represent a promised result for any patient.

Candidacy

Are you a candidate for corneal transplant surgery?

You may be a good candidate if

  • You have advanced keratoconus where cross-linking (CXL) has failed or is no longer suitable due to corneal thickness below 380 µm, or K-max has progressed to scarring despite prior treatment.
  • You have Fuchs endothelial corneal dystrophy causing visual decline from endothelial cell failure and corneal oedema (bullous keratopathy).
  • You have a corneal scar from prior infection (bacterial, fungal, herpetic) or injury that reaches the visual axis and reduces corrected vision below functional levels.
  • You have corneal stromal oedema or decompensation following prior intraocular surgery (cataract, glaucoma shunts, vitreoretinal procedures).
  • Your endothelial cell count is below 500 cells/mm² with progressive corneal thickening and recurrent episodes of painful bullous keratopathy.
  • You have a congenital corneal opacity or anterior dystrophy with a healthy endothelium (DALK candidacy).

Surgery may need to be deferred or reconsidered if

  • Active corneal infection (bacterial keratitis, fungal keratitis, acanthamoeba) — the infection must be fully resolved before transplant surgery is scheduled.
  • Uncontrolled glaucoma with elevated intraocular pressure — IOP must be managed before transplant to protect the donor graft.
  • Severe ocular surface disease (dry eye, lid malposition, cicatricial conjunctivitis) — surface health directly determines graft survival and must be optimised pre-operatively.
  • Significant posterior segment disease (dense vitreous haemorrhage, proliferative retinopathy, severe macular disease) where corneal clarity alone will not restore meaningful vision — realistic visual prognosis must be established first.
  • Patients with only one functioning eye require extended counselling and must weigh the risk of a period of reduced vision during recovery before agreeing to elective transplant.

Disclaimer. Information on this page is consistent with the American Academy of Ophthalmology (AAO) Preferred Practice Pattern on Corneal Edema and Opacification (2018), Cornea Society Preferred Practice Patterns, NICE Interventional Procedures Guidance IPG585 (DMEK, 2017), and Eye Bank Association of America (EBAA) tissue grading standards. It is educational and not a clinical recommendation. The only reliable way to determine whether DALK, PK or DMEK is appropriate for your corneal pathology is a specialist evaluation using Pentacam topography, AS-OCT, specular endothelial count and slit-lamp biomicroscopy — which is why our consultation is provided at no charge and without obligation.

Risks & outcomes

Realistic outcomes — the risks that matter

Corneal transplant is a major surgical procedure. Our cornea specialist team explains these risks in full during the pre-operative consultation; they are listed here in the same plain terms:

Immunological rejection

Endothelial rejection occurs in 10 to 20 percent of PK cases at 5 years, under 4 percent with DMEK, and near zero for the endothelial layer with DALK. Rejection presents as pain, redness, photophobia and sudden vision blurring — it is a medical emergency. Early intensive topical steroid treatment reverses most rejection episodes when started within 24 hours of symptom onset. Patients receive a written rejection symptom card at discharge.

Primary graft failure

About 2 to 5 percent of donor grafts fail to function within the first week despite technically correct surgery — a consequence of donor tissue quality or undetected endothelial compromise. EBAA-graded tissue with pre-operative endothelial count reduces but does not eliminate this risk. Regrafting is the established management.

Graft infection

Post-keratoplasty infectious keratitis occurs in under 2 percent of cases. Risk is highest in the first month during epithelial healing. Prophylactic topical antibiotics are prescribed for the first month; any new pain, discharge or infiltrate is evaluated as urgent.

Elevated intraocular pressure

Post-keratoplasty steroid response (raised IOP from long-term steroid drops) occurs in 20 to 35 percent of patients. IOP is monitored at every follow-up visit; a topical IOP-lowering agent is added when pressure exceeds 21 mmHg. Steroid responders are identified early and managed to protect the optic nerve.

Irregular astigmatism (PK / DALK)

Full-thickness and lamellar transplants heal with variable corneal curvature — irregular astigmatism of 3 to 6 dioptres is common. Spectacles or rigid gas permeable contact lenses provide good correction in most cases; selective suture removal and corneal relaxing incisions are used when topography-guided adjustment is appropriate. Visual rehabilitation typically takes 12 to 18 months after PK.

FAQ

Frequently asked questions about corneal transplant & keratoplasty

How long does a corneal transplant last?

Graft survival depends on the technique and underlying indication. Penetrating keratoplasty (PK) grafts for keratoconus have 5-year survival rates of 90 to 95 percent and 10-year rates of 72 to 78 percent according to Eye Bank Association of America data and Australian Corneal Graft Registry figures. DMEK grafts for Fuchs dystrophy have reported 5-year survival above 95 percent, largely because endothelial rejection rates are substantially lower than PK. DALK grafts avoid endothelial rejection entirely; the main attrition risk is stromal rejection, which occurs in fewer than 5 percent of cases. Second grafts (regrafting) are possible and succeed at somewhat lower but still clinically meaningful rates.

What are the signs of corneal transplant rejection and what should I do?

The classic rejection episode presents with four symptoms that tend to appear together: redness of the eye, photophobia (light sensitivity), sudden decrease in vision clarity, and eye pain or discomfort. These symptoms can appear at any point after transplant — weeks, months or even years post-operatively. If you experience any combination of these, contact Eyeglow's coordinator immediately and go to your local emergency eye unit the same day. Early intensive topical steroids (prednisolone acetate 1% every 1 to 2 hours during waking hours) reverse most acute rejection episodes when initiated within 24 to 48 hours. Delayed treatment significantly reduces the chance of reversal. Every Eyeglow keratoplasty patient receives a written rejection symptom card in their language at discharge.

What is DMEK and how does it compare to DSAEK?

Both DMEK (Descemet Membrane Endothelial Keratoplasty) and DSAEK (Descemet Stripping Automated Endothelial Keratoplasty) replace only the back layer of the cornea (Descemet membrane and endothelium) through a small incision, preserving the patient's clear anterior stroma. The difference is tissue thickness: DSAEK includes a thin layer of donor stroma (80 to 160 µm), while DMEK is a pure Descemet/endothelial scroll of 15 to 25 µm. This thinner DMEK tissue conforms more precisely to the posterior corneal surface, resulting in faster visual recovery (weeks rather than months), lower rejection rates (1 to 4 percent vs 10 percent for PK) and better final visual acuity (60 to 70 percent of DMEK patients achieve 20/25 or better at 1 year). At Eyeglow we offer DMEK as the standard endothelial technique for Fuchs dystrophy and bullous keratopathy cases with suitable donor tissue.

What is DALK and when is it preferred over penetrating keratoplasty?

DALK — Deep Anterior Lamellar Keratoplasty — removes the anterior 95 percent of the corneal stroma while preserving the patient's own Descemet membrane and endothelium. Because the patient's endothelium is retained, the risk of endothelial rejection is near zero — the most serious long-term complication of penetrating keratoplasty. DALK is preferred for keratoconus with advanced scarring, corneal stromal dystrophies (macular, granular), anterior corneal scars from infection or injury, and keratoconus where cross-linking has failed — as long as the patient's endothelium is healthy (cell count ≥1,000 cells/mm²). PK is chosen instead when disease reaches the endothelium, when big-bubble DALK conversion to PK occurs intraoperatively (about 5 to 10 percent), or when a prior failed full-thickness graft is being regrafted.

Do I need to take steroid drops for life after a corneal transplant?

Long-term topical steroids are necessary after all full-thickness (PK) and endothelial (DMEK) transplants and are typically used for one to several years with gradual tapering — and often indefinitely at a low maintenance dose. The goal is to suppress immunological rejection, which can occur at any point post-operatively. With DALK, the endothelium is the patient's own tissue, so the risk of endothelial rejection is near zero; many DALK surgeons taper steroids more aggressively at one year, though a low maintenance dose is still commonly continued. Our cornea specialist team provides a written individualised steroid tapering schedule with each patient's discharge summary, adjusted according to the graft type, IOP response (steroid responders are identified at each follow-up) and rejection risk profile.

Can the donor cornea be matched to my blood type or tissue type?

Unlike organ transplants (kidney, liver, heart), corneal allografts do not routinely require ABO blood type or HLA tissue matching, because the healthy cornea is an "immune-privileged" site — it lacks direct blood vessel supply and lymphatic drainage, limiting immune surveillance. This is why routine corneal transplants can proceed without the extended waiting periods associated with solid organ transplants. However, HLA matching is considered in high-risk cases — vascularised corneas from prior failed grafts, chemical burns, or severe ocular surface disease — where the immune privilege has been disrupted. EBAA-graded donor tissue is screened for infectious diseases (HIV, HBV, HCV, syphilis, CMV) and donor medical/social history is reviewed, but routine HLA matching is not standard practice for primary keratoplasty.

What happens if the corneal transplant is rejected or fails?

An acute rejection episode, when treated early, can often be reversed with intensive topical steroids — most corneas survive an initial rejection episode without permanent damage if treatment starts within 24 to 48 hours. If a graft fails despite maximum steroid therapy, or if primary graft failure occurs within the first month, regrafting (a second corneal transplant) is the standard treatment. Second grafts carry a somewhat higher rejection risk than first grafts because the surgical bed is more vascularised, but they still achieve 5-year survival rates of 60 to 75 percent for PK and higher for repeat endothelial keratoplasty. At Eyeglow, our complication insurance policy covers eligible complications including those requiring emergency medical intervention during the recovery period.

How much does corneal transplant surgery cost at Eyeglow?

Eyeglow Health all-inclusive packages including EBAA-graded donor tissue, surgery, 7 nights hotel, transfers, 1-year structured follow-up and complication insurance are €7,000 – €10,000 per eye. Your final, personalised quote is confirmed after our cornea specialist team reviews your topography and confirms the indicated technique — with no obligation.

What is the success rate of corneal transplant surgery?

Graft success rates depend on technique and indication. For keratoconus treated with PK or DALK — the healthiest transplant indication — 5-year graft survival exceeds 90 percent across major registries (Australian Corneal Graft Registry, UK Transplant Register, EBAA data). Fuchs dystrophy treated with DMEK shows 5-year survival above 95 percent. Outcomes are less favourable in high-risk cases: regrafts, vascularised corneas (from chemical burns or Stevens-Johnson), active ocular surface disease, or uncontrolled glaucoma. Our cornea specialist team discusses the realistic expected outcome for your specific indication, your fellow eye status and systemic factors during the pre-operative consultation — not as a category average.

Is the second eye treated immediately or after the first graft matures?

In bilateral corneal disease (Fuchs dystrophy, keratoconus) both eyes are rarely transplanted simultaneously. Standard practice is to stage the procedures: allow the first eye to recover functional vision — typically 3 to 6 months for DMEK, 6 to 12 months for DALK or PK — before considering the fellow eye. This approach maintains binocular function during the critical early healing period, allows the steroid and immune management of the first graft to be established, and lets the patient develop familiarity with the post-operative routine before the second eye is operated. In some bilateral cases where one eye is already non-functional from previous failed surgery, sequential rapid staging is considered.

How is corneal transplant in Turkey different from corneal transplant in my home country?

The surgical technique and donor tissue standards are the same — Eyeglow uses EBAA-graded tissue, Cornea Society technique guidelines and the same intraoperative equipment (femtosecond-assisted trephination where applicable, microkeratome for DALK dissection, DMEK pre-stripped tissue) as used in major European and North American cornea centres. What differs is the structured package model: pre-operative imaging, surgery, hospital stay, 7 nights hotel, airport transfers and a 12-month follow-up plan are included in one itemised price, with a single named coordinator throughout. In home-country settings, these are typically billed separately, coordination falls on the patient, and follow-up appointment availability varies. The clinical outcome standard — rejection-free graft survival, endothelial cell preservation, final corrected vision — is the same.

Can I wear contact lenses after corneal transplant surgery?

Contact lens wear is restricted during the healing phase — typically 3 months for DMEK (while the graft settles), and 12 months or until sutures are removed for PK and DALK. After the recovery period, many patients benefit from rigid gas permeable (RGP) or mini-scleral contact lenses to manage residual irregular astigmatism, particularly after PK. Soft lens wear is usually avoided on transplanted corneas because of sensitivity, but this is assessed individually. Contact lens fitting after keratoplasty is a specialised skill; our cornea specialist team coordinates referral to a cornea-specialist contact lens fitting service as part of the 12-month follow-up pathway.

Why choose Eyeglow Health for corneal transplant rather than a domestic hospital?

Corneal transplantation requires three aligned elements: a skilled cornea specialist, consistent access to EBAA-graded donor tissue, and a structured follow-up programme. At Eyeglow Health, every transplant candidate is reviewed by our cornea specialist team before the tissue request is filed. Our donor tissue is procured through a partner eye bank to EBAA standards — endothelial count confirmed before dispatch. The 12-month follow-up plan is included in the package, not billed per visit. For patients whose home country has long NHS or insurance waiting lists, offers limited access to DMEK or DALK (which require specialist cornea centres), or lacks structured post-keratoplasty care pathways, Eyeglow provides a clinically equivalent alternative with transparent pricing.
Get a free quote